Catalytic autoantibodies in multiple sclerosis: Pathogenetic and clinical aspects

Author： Misikov V.   Kimova M.   Durova O.   Gabibov A.   Suchkov S.   Vorob’ev I.   Ponomarenko N.  

Publisher： Springer Publishing Company

ISSN： 0007-4888

Source： Bulletin of Experimental Biology and Medicine, Vol.139, Iss.1, 2005-01, pp. : 85-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The genetic analysis of multiple sclerosis

By Sawcer S.   Goodfellow P.N.   Compston A.  

Trends in Genetics, Vol. 13, Iss. 6, 1997-06 ,pp. : 234-239

Elsevier

Access to resources Recommend Favorite

Therapeutic Antibodies in Multiple Sclerosis

By  

Neurodegenerative Diseases, Vol. 5, Iss. 1, 2007-12 ,pp. : 5-7

Karger

Access to resources Recommend Favorite

Gene Expression Studies in Multiple Sclerosis

By  

Current Genomics, Vol. 8, Iss. 3, 2007-05 ,pp. : 181-189

Bentham Science Publishers

Access to resources Recommend Favorite

Measuring Activity Patterns Using Actigraphy in Multiple Sclerosis

By Kos Daphne   Nagels Guy   D'Hooghe Marie B.   Duquet William   Ilsbroukx Stephan   Delbeke Stijn   Kerckhofs Eric  

Chronobiology International, Vol. 24, Iss. 2, 2007-03 ,pp. : 345-356

Informa Healthcare

Access to resources Recommend Favorite

Intravenous Polyclonal Human Immunoglobulins in Multiple Sclerosis

By  

Neurodegenerative Diseases, Vol. 5, Iss. 1, 2007-12 ,pp. : 8-15

Karger

Access to resources Recommend Favorite